Bond & Devick Financial Network, Inc.
Position in LLY — ELI LILLY & Co
CIK 1843495
ST. LOUIS PARK, MN
Position in LLY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$436,592
+$101,796 QoQ
Shares Held
364
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#3,860
of 4,605 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bond & Devick Financial Network, Inc. holds $6,097,156 across 9 Drug Manufacturers - General names. LLY ranks #5 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,177 | $1,822,742 | |
| 2 | AMGN |
Amgen Inc
|
3,711 | $1,343,827 | |
| 3 | NVO |
Novo Nordisk A S
|
15,422 | $739,330 | |
| 4 | GSK |
GSK plc
|
8,530 | $447,142 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
364 | $436,592 | |
| 6 | PFE |
Pfizer Inc
|
18,088 | $435,559 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,927 | $376,119 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,156 | $272,389 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $436,592 | 364 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $334,796 | 364 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $385,810 | 359 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $319,697 | 419 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $311,812 | 400 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $330,364 | 400 | Shares | Sole | 2025-04-09 | |
| No filing history on record for this holder in this stock. | ||||||